LabStyle Innovations Appoints Renowned Diabetes Expert to Its Board of Directors
Complete the form below to unlock access to ALL audio articles.
Dr. Raz expands the size of LabStyle’s board to seven directors, and he will serve on the Compensation Committee of the board. He will continue to lead LabStyle’s Scientific Advisory Committee. LabStyle made this announcement from the American Diabetes Association’s 73rd Scientific Sessions, which is underway at the McCormick Place Convention Center in Chicago.
Dr. Raz is a world-renowned leader in diabetes treatment and research, and is an advisor to leading companies in the field. He currently serves as a professor of internal medicine at Hadassah University Medical Center in Israel and is head of the Diabetes Unit and Research Center at Hadassah. He is also the head of the Israel National Council of Diabetes of the Israel Ministry of Health, which is responsible for formulating national policies, the President of D-Cure, a diabetes not-for-profit organization, and the head of the Israel Diabetes Research Group.
“Dr. Raz strengthens our Board of Directors with his deep expertise in diabetes as a researcher, professor and tireless advocate for better treatment,” said Dr. Oren Fuerst, LabStyle’s Chairman and Chief Executive Officer. “He is highly visible and well regarded in the diabetes community worldwide, and will be a valuable asset to our company as we seek to bring the many benefits of Dario to diabetics around the world.”
Commenting on his appointment, Dr. Raz said, “New tools and treatments for diabetics will help to contain the devastating impact of the growing diabetes epidemic. Information is the first step in improving outcomes. Dario is an innovative device and data-management system that I believe will catalyze more frequent testing due to its all-in-one design, while its many features, including the ability to share data in real-time with caregivers, will enable personalized care. In addition web-based social interactions between patients catalyzed by Dario create the potential for significant benefits through greater patient compliance.”
At Hadassah Hebrew University Hospital, Dr. Raz is currently leading several international clinical studies involving prevention and treatment of type 1 diabetes. Dr. Raz has published extensively on diabetes with more than 190 publications to his credit, and he also serves as a member of several medical editorial boards. Dr. Raz has organized several international meetings on diabetes, the largest being CODHy – Controversies in Obesity, Diabetes and Hypertension.
